MMA Offering Discounted Pricing on Opioid Prescribing Training to Fulfill DEA Requirement

March 28, 2024

As of June 27, 2023, U.S. Drug Enforcement Administration (DEA) license holders, upon initial registration or renewal, are required to complete at least eight hours of training in the treatment or management of patients with opioid or other substance use disorders. 

The MMA has partnered with Clinical Education Alliance (CEA) to offer a one-stop resource to fulfill this training.  

If you have already completed the MMA’s Best Practices in Prescribing Opioids and Other Controlled Substances, you can apply the two hours of credit earned toward the eight-hour requirement. This course was available from January 22, 2020, until December 31, 2022. If you need evidence of completion, you can contact the MMA.  

For the six remaining hours (or all eight if you haven’t completed any training), click here.  

Developed in collaboration with renowned experts, this comprehensive training equips healthcare professionals with the necessary knowledge and skills to optimize patient care while meeting the requirements set forth by the DEA. Dive into key topics, including DEA regulations, reimbursement codes for substance use disorder intervention, substance use disorders, pain management, and much more. 

Gain a deep understanding of best practices and evidence-based approaches for safe and effective prescribing practices. Led by experienced faculty, the course offers an interactive learning experience with engaging lectures, case studies, and interactive discussions, fostering collaboration and knowledge exchange with peers. Earn course credits including AMA PRA Category 1, Board MOC and MIPS improvement activity. 

Learn at your own pace with the self-guided on-demand course. MMA members can apply the following code (MNMED100) to receive a $100 discount from the original course cost of $299.